Bedtime magnesium sprays have moved from niche wellness circles onto shelves at Target, Walmart, CVS and Ulta, promising deeper sleep without the stomach issues of oral supplements. But doctors and ...
BOZEMAN, Mont., Jan. 22, 2025 /PRNewswire/ -- Atrial fibrillation (AF) is the most common abnormal heart rhythm affecting 6 million people in the USA and can cause strokes and heart failure.
Proponents of magnesium calming creams and sprays claim they can help with sleep, anxiety, stress, and more. An expert weighs ...
Our study demonstrated that among patients with a baseline SMC of 1.4–1.8 mg/dL, the use of i.v. magnesium sulfate was associated with a greater increase in SMC than the use of oral magnesium oxide.
Cancer chemotherapeutic error in hospitalized patients: Attributable damages and extra costs. Risk factors for nausea and vomiting (NV) following highly or moderately ...
Magnesium glycerophosphate is a magnesium salt which is available as a tablet, capsule, liquid solution or liquid suspension for oral use. This evidence summary considers the use of oral magnesium ...
Magnesium is an essential mineral that supports more than 300 biochemical reactions in the body. It plays a crucial role in ...
Medically reviewed by Paria Sanaty Zadeh, PharmD Why this matters: Magnesium lotion is a promising remedy for common concerns ...
Affecting around 300 million people worldwide, asthma is generally treated with inhalations of beta-agonists and corticosteroids. Recently, this inflammatory disease has been associated with low ...
While too little calcium can trigger bone problems, insufficient magnesium may spell trouble for your brain, suggests a study published in the January 28 issue of Neuron. An international research ...
Data collection was performed from October 18, 2009, through January 28, 2010. The pharmacy information system identified 525 patients who received any dose of i.v. magnesium sulfate or oral magnesium ...
No published clinical trials comparing magnesium glycerophosphate with placebo or active comparator for preventing recurrent hypomagnesaemia after treatment with intravenous magnesium were identified.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results